{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:11Z","timestamp":1793414111298,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jacc.2021.10.035","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T17:47:39Z","timestamp":1641232059000},"page":"66-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":194,"title":["Coronary Atherosclerotic Plaque\u00a0Regression"],"prefix":"10.1016","volume":"79","author":[{"given":"Luke P.","family":"Dawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh","family":"Nerleker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Layland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2021.10.035_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005375","article-title":"Mortality from ischemic heart disease","volume":"12","author":"Nowbar","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2021.10.035_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12296","article-title":"Thrombosis formation on atherosclerotic lesions and plaque rupture","volume":"276","author":"Badimon","year":"2014","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"12","author":"Camare","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.jacc.2021.10.035_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003316","article-title":"Noninvasive imaging of atherosclerotic plaque progression: status of coronary computed tomography angiography","volume":"8","author":"Sandfort","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2021.10.035_bib5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.92.5.1355","article-title":"A\u00a0definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"92","author":"Stary","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.10.035_bib6","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jacc.2019.08.012","article-title":"From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review","volume":"74","author":"Ahmadi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","article-title":"Compensatory enlargement of human atherosclerotic coronary arteries","volume":"316","author":"Glagov","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib8","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.jacc.2016.08.055","article-title":"A\u00a0prospective natural history study of coronary atherosclerosis using fractional flow reserve","volume":"68","author":"Barbato","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2021.10.035_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006347","article-title":"Serial 3-vessel optical coherence tomography and intravascular ultrasound analysis of changing morphologies associated with lesion progression in patients with stable angina pectoris","volume":"10","author":"Yamamoto","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2021.10.035_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacc.2014.05.039","article-title":"High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial","volume":"64","author":"Puchner","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcct.2020.11.002","article-title":"Society of Cardiovascular Computed Tomography \/ North American Society of Cardiovascular Imaging - expert consensus document on coronary CT imaging of atherosclerotic plaque","volume":"15","author":"Shaw","year":"2021","journal-title":"J\u00a0Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jacc.2021.10.035_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2015.05.069","article-title":"Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up","volume":"66","author":"Motoyama","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacc.2009.02.068","article-title":"Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome","volume":"54","author":"Motoyama","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.114.300760","article-title":"High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies","volume":"114","author":"Feig","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2021.10.035_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006973","article-title":"Computed tomographic coronary angiography-derived plaque characteristics predict major adverse cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Nerlekar","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2021.10.035_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCIMAGING.113.001047","article-title":"Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events","volume":"7","author":"Bittencourt Marcio","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2021.10.035_bib17","first-page":"368","article-title":"Characterization of coronary atherosclerosis by intravascular imaging modalities","volume":"6","author":"Honda","year":"2016","journal-title":"Cardiovasc"},{"key":"10.1016\/j.jacc.2021.10.035_bib18","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/eurheartj\/ehq280","article-title":"Imaging of coronary atherosclerosis: intravascular ultrasound","volume":"31","author":"Garcia-Garcia","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/eurheartj\/ehp433","article-title":"Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis","volume":"31","author":"Prati","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jcmg.2011.03.020","article-title":"Intravascular optical imaging technology for investigating the coronary artery","volume":"4","author":"Suter","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008404","article-title":"Serial Coronary Plaque Assessment Using Computed Tomography Coronary Angiography","volume":"12","author":"Kiran Munnur","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2021.10.035_bib22","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jcmg.2017.07.023","article-title":"Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression: Results From a Quantitative Semiautomated Coronary Artery Plaque Analysis","volume":"11","author":"Ceponiene","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11883-016-0584-3","article-title":"PET Imaging of atherosclerotic disease: advancing plaque assessment from anatomy to pathophysiology","volume":"18","author":"Evans","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2021.10.035_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008574","article-title":"Molecular coronary plaque imaging using 18F-fluoride","volume":"12","author":"Moss","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2021.10.035_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.10.035_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcmg.2019.03.033","article-title":"Noninvasive imaging to assess atherosclerotic plaque composition and disease activity: coronary and carotid applications","volume":"13","author":"Daghem","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib27","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1039\/D0NR00599A","article-title":"Recent advances in molecular imaging of atherosclerotic plaques and thrombosis","volume":"12","author":"Qiao","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.jacc.2021.10.035_bib28","doi-asserted-by":"crossref","first-page":"13827","DOI":"10.1038\/s41598-019-50100-8","article-title":"Dual-probe molecular MRI for the in\u00a0vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling","volume":"9","author":"Reimann","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2021.10.035_bib29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jacc.2018.02.085","article-title":"Cardiovascular disease prevention by diet modification: JACC health promotion series","volume":"72","author":"Yu","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib30","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.280.23.2001","article-title":"Intensive lifestyle changes for reversal of coronary heart disease","volume":"280","author":"Ornish","year":"1998","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jacc.2021.10.035_bib31","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jcmg.2020.10.019","article-title":"High-risk coronary plaque regression after intensive lifestyle intervention in nonobstructive coronary disease: a randomized study","volume":"14","author":"Henzel","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcmg.2011.11.012","article-title":"Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS","volume":"5","author":"Hattori","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib33","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.jacc.2021.10.035_bib34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.10.035_bib35","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9149(97)00221-X","article-title":"Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin","volume":"79","author":"Takagi","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib37","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.amjcard.2014.08.012","article-title":"Coronary atheroma regression and plaque characteristics assessed by grayscale and radiofrequency intravascular ultrasound after aerobic exercise","volume":"114","author":"Madssen","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1253\/circj.CJ-18-0738","article-title":"Impact of physical activity on coronary plaque volume and components in acute coronary syndrome patients after early phase II cardiac rehabilitation","volume":"83","author":"Nishitani-Yokoyama","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib39","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1253\/circj.CJ-09-0705","article-title":"Coronary plaque regression and lifestyle modification in patients treated with pravastatin. - Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol","volume":"74","author":"Tani","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.117.027834","article-title":"Relationship Between Lifelong Exercise Volume and Coronary Atherosclerosis in Athletes","volume":"136","author":"Aengevaeren","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.10.035_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.116.026964","article-title":"Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile","volume":"136","author":"Merghani","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.10.035_bib42","first-page":"29","article-title":"Smoking, smoking cessation, and measures of subclinical atherosclerosis in multiple vascular beds in Japanese men","volume":"5","author":"Hisamatsu","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.10.035_bib43","first-page":"354","article-title":"Comparison of coronary atherosclerotic plaque burden and composition of culprit lesions between cigarette smokers and non-smokers by in\u00a0vivo virtual histology intravascular ultrasound","volume":"27","author":"Bolorunduro","year":"2015","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141093","article-title":"Smoking in relation to coronary atherosclerotic plaque burden, volume and composition on intravascular ultrasound","volume":"10","author":"Buljubasic","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2021.10.035_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jvs.2010.12.039","article-title":"The effect of alcohol on atherosclerotic plaque composition and cardiovascular events in patients with arterial occlusive disease","volume":"54","author":"Gisbertz","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jacc.2021.10.035_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147822","article-title":"Associations between tobacco, alcohol, and drug use with coronary artery plaque among HIV-infected and uninfected men in the multicenter AIDS Cohort Study","volume":"11","author":"Kelly","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jacc.2021.10.035_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ahj.2005.09.016","article-title":"Is alcohol consumption associated with calcified atherosclerotic plaque in the coronary arteries and aorta?","volume":"152","author":"Ellison","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib48","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.10.035_bib49","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.10.035_bib51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","article-title":"Safety and efficacy of statin therapy","volume":"15","author":"Adhyaru","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","article-title":"Statin Toxicity","volume":"124","author":"Ward","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2021.10.035_bib53","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","volume":"54","author":"Hiro","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jcin.2009.03.015","article-title":"Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis","volume":"2","author":"Hong","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.10.035_bib56","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.jacc.2004.09.081","article-title":"Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound","volume":"45","author":"Kawasaki","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","article-title":"Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy)","volume":"62","author":"Kini","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib58","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1253\/circj.CJ-12-0325","article-title":"Virtual histology finding and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients: the VENUS study","volume":"76","author":"Lee","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jcin.2009.04.016","article-title":"Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound","volume":"2","author":"Nasu","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.10.035_bib60","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of 2 intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib61","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib62","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ahj.2011.11.004","article-title":"Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis","volume":"163","author":"Nozue","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib64","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2016.02.014","article-title":"Effect of statin treatment on modifying plaque composition: a double-blind, randomized study","volume":"67","author":"Park","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib65","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehu373","article-title":"Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study","volume":"36","author":"Raber","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib66","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1253\/circj.CJ-09-0358","article-title":"Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)","volume":"73","author":"Takayama","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib67","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1253\/circj.CJ-08-1051","article-title":"Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin","volume":"73","author":"Toi","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib68","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ahj.2005.03.059","article-title":"Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study","volume":"150","author":"Yokoyama","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/hc2901.093188","article-title":"Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease","volume":"104","author":"Schartl","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.10.035_bib70","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12933-017-0637-0","article-title":"Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology","volume":"16","author":"Kovarnik","year":"2017","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.jacc.2021.10.035_bib71","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of statins on coronary atherosclerotic plaques: the PARADIGM Study","volume":"11","author":"Lee","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib72","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009750","article-title":"Impact of clinical characteristics and statins on coronary plaque progression by serial computed tomography angiography","volume":"13","author":"Smit","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2021.10.035_bib73","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jcmg.2016.04.013","article-title":"Impact of intensive LDL cholesterol lowering on coronary artery atherosclerosis progression: a serial CT angiography study","volume":"10","author":"Shin","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib74","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jcmg.2017.07.011","article-title":"Effect of early pitavastatin therapy on coronary fibrous-cap thickness assessed by optical coherence tomography in patients with acute coronary syndrome: the ESCORT study","volume":"11","author":"Nishiguchi","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib75","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jcmg.2018.08.024","article-title":"Changes in coronary plaque composition in patients with acute myocardial infarction treated with high-intensity statin therapy (IBIS-4): a serial optical coherence tomography study","volume":"12","author":"Raber","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib76","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2014.08.045","article-title":"Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study","volume":"64","author":"Komukai","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1536\/ihj.14-311","article-title":"Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease","volume":"56","author":"Masuda","year":"2015","journal-title":"Int Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1253\/circj.CJ-11-0730","article-title":"Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study","volume":"76","author":"Kovarnik","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcme.2014.03.001","article-title":"Effect of combination of ezetimibe and a statin on coronary plaque regression in patients with acute coronary syndrome ZEUS trial (eZEtimibe Ultrasound Study)","volume":"3","author":"Nakajima","year":"2014","journal-title":"IJC Metabolic & Endocrine"},{"key":"10.1016\/j.jacc.2021.10.035_bib80","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jacc.2015.05.065","article-title":"Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS Trial","volume":"66","author":"Tsujita","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib81","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.carrev.2016.11.010","article-title":"Influence of ezetimibe in addition to high-dose atorvastatin therapy on plaque composition in patients with ST-segment elevation myocardial infarction assessed by serial: Intravascular ultrasound with iMap: the OCTIVUS trial","volume":"18","author":"Hougaard","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib82","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1253\/circj.CJ-17-0193","article-title":"Effect of ezetimibe on stabilization and regression of intracoronary plaque - the ZIPANGU study","volume":"81","author":"Ueda","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib83","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1253\/circj.CJ-17-0598","article-title":"Effects of ezetimibe-statin combination therapy on coronary atherosclerosis in acute coronary syndrome","volume":"82","author":"Hibi","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib84","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jacc.2018.04.054","article-title":"The evolving future of PCSK9 inhibitors","volume":"72","author":"Rosenson","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib85","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib86","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1253\/circj.CJ-19-0412","article-title":"Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndrome - the ODYSSEY J-IVUS trial","volume":"83","author":"Ako","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2021.10.035_bib87","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib88","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib89","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib90","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib91","first-page":"592S","article-title":"Mechanisms of action of (n-3) fatty acids","volume":"142","author":"Calder","year":"2012","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jacc.2021.10.035_bib92","first-page":"537","article-title":"A\u00a0randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins","volume":"70","author":"Watanabe","year":"2017","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib93","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1253\/circj.CJ-15-0813","article-title":"Effects of the addition of eicosapentaenoic acid to strong statin therapy on inflammatory cytokines and coronary plaque components assessed by integrated backscatter intravascular ultrasound","volume":"80","author":"Niki","year":"2016","journal-title":"Circ J"},{"issue":"12","key":"10.1016\/j.jacc.2021.10.035_bib94","article-title":"Effect of eicosapentaenoic and docosahexaenoic acids added to statin therapy on coronary artery plaque in patients with coronary artery disease: a randomized clinical trial","volume":"6","author":"Alfaddagh","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.10.035_bib95","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2019.04.213","article-title":"An omega-3 fatty acid plasma index\u00a0\u22654% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment","volume":"285","author":"Alfaddagh","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2021.10.035_bib96","article-title":"Effects of fatty acid therapy in addition to strong statin on coronary plaques in acute coronary syndrome: an optical coherence tomography study","volume":"9","author":"Kita","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.10.035_bib97","doi-asserted-by":"crossref","first-page":"e1099","DOI":"10.4244\/EIJ-D-18-01073","article-title":"Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial","volume":"15","author":"Kuroda","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2021.10.035_bib98","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2014.02.025","article-title":"Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma","volume":"234","author":"Nishio","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2021.10.035_bib99","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5551\/jat.25593","article-title":"Impact of eicosapentaenoic acid treatment on the fibrous cap thickness in patients with coronary atherosclerotic plaque: an optical coherence tomography study","volume":"22","author":"Yamano","year":"2015","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacc.2021.10.035_bib100","first-page":"29","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial","volume":"29","author":"Budoff","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib102","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH Randomized Clinical Trial","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib103","article-title":"Association of serum lipoprotein (a) levels and coronary atheroma volume by intravascular ultrasound","volume":"9","author":"Huded","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.10.035_bib104","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.amjcard.2016.06.020","article-title":"Relation of plasma lipoprotein(a) to subclinical coronary plaque volumes, three-vessel and left main coronary disease, and severe coronary stenoses in apparently healthy African-Americans with a family history of early-onset coronary artery disease","volume":"118","author":"Kral","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10557-016-6654-5","article-title":"Future directions to establish lipoprotein(a) as a treatment for atherosclerotic cardiovascular disease","volume":"30","author":"Stein","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2021.10.035_bib106","first-page":"E204","article-title":"Effect of extended-release niacin on saphenous vein graft atherosclerosis: insights from the atherosclerosis lesion progression intervention using niacin extended release in saphenous vein grafts (ALPINE-SVG) Pilot Trial","volume":"27","author":"Kotsia","year":"2015","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib107","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib108","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/M14-2957","article-title":"Effects of proprotein convertase subtilisin\/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis","volume":"163","author":"Navarese","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13063-020-04291-5","volume":"21","author":"Kwon","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2021.10.035_bib110","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib111","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacc.2009.09.062","article-title":"Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial","volume":"55","author":"Hirohata","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib112","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjcard.2007.02.073","article-title":"Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study)","volume":"100","author":"Rodriguez-Granillo","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijcard.2011.01.030","article-title":"Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound","volume":"158","author":"Han","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib114","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.2013.277169","article-title":"Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial","volume":"310","author":"Nicholls","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jacc.2021.10.035_bib116","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib117","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2018.08.007","article-title":"Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis","volume":"206","author":"Lee","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ahj.2019.02.014","article-title":"Apixaban versus warfarin in evaluation of progression of\u00a0atherosclerotic and calcified plaques (prospective randomized trial)","volume":"212","author":"Win","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib119","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcmg.2019.07.021","article-title":"Relationship of anticoagulant therapies on coronary plaque progression: a longitudinal CTA Analysis","volume":"13","author":"Beyer","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib120","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jcmg.2017.04.010","article-title":"Warfarin use is associated with progressive coronary arterial calcification: insights from serial intravascular ultrasound","volume":"11","author":"Andrews","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2021.10.035_bib121","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.299.13.1561","article-title":"Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib122","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1464-5491.2011.03458.x","article-title":"Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance","volume":"29","author":"Yang","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib123","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.109.881003","volume":"121","author":"Gerstein","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.10.035_bib124","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0735-1097(02)01955-1","article-title":"Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART)","volume":"40","author":"Matsuzaki","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib125","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib126","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/eurheartj\/ehu171","article-title":"Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial","volume":"35","author":"Tardif","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib127","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMoa054699","article-title":"Effect of ACAT inhibition on the progression of coronary atherosclerosis","volume":"354","author":"Nissen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib128","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib129","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","article-title":"Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial","volume":"297","author":"Tardif","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib130","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.jacc.2009.12.067","article-title":"A\u00a0first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome","volume":"55","author":"Waksman","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.10.035_bib131","doi-asserted-by":"crossref","first-page":"816","DOI":"10.5551\/jat.22657","article-title":"Effects of combination therapy with cilostazol and probucol versus monotherapy with cilostazol on coronary plaque, lipid and biomarkers: SECURE study, a double-blind randomized controlled clinical trial","volume":"21","author":"Ko","year":"2014","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacc.2021.10.035_bib132","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2006.11.039","article-title":"Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial","volume":"197","author":"Tardif","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2021.10.035_bib133","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40256-015-0146-z","article-title":"Effect of the BET protein inhibitor, RVX-208, on progression of coronary atherosclerosis: results of the phase 2b, randomized, double-blind, multicenter, ASSURE trial","volume":"16","author":"Nicholls","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2021.10.035_bib134","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.10.035_bib135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12906-020-02932-5","article-title":"The effect of aged garlic extract on the atherosclerotic process \u2013 a randomized double-blind placebo-controlled trial","volume":"20","author":"Wlosinska","year":"2020","journal-title":"BMC Complementary Medicine and Therapies"},{"key":"10.1016\/j.jacc.2021.10.035_bib136","first-page":"1457","article-title":"Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with diabetes: A randomized, double-blind, placebo-controlled study","volume":"19","author":"Shaikh","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jacc.2021.10.035_bib137","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2019.03.005","article-title":"Coronary atheroma regression and adverse cardiac events: a systematic review and meta-regression analysis","volume":"284","author":"Bhindi","year":"2019","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jacc.2021.10.035_bib138","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1148\/radiol.10100681","article-title":"Automated three-dimensional quantification of noncalcified coronary plaque from coronary CT angiography: comparison with intravascular US","volume":"257","author":"Dey","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jacc.2021.10.035_bib139","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ahj.2020.10.052","volume":"231","author":"Gibson","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.10.035_bib140","article-title":"Clinical and laboratory predictors for plaque erosion in patients with acute coronary syndromes","volume":"8","author":"Yamamoto","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.10.035_bib141","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the mechanisms of acute coronary syndromes","volume":"124","author":"Libby","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2021.10.035_bib142","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehx786","article-title":"Plaque erosion: a new in\u00a0vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes","volume":"39","author":"Partida","year":"2018","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721080840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721080840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:47:15Z","timestamp":1760017635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721080840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0735109721080840"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.10.035","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary Atherosclerotic Plaque\u00a0Regression","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}